A major new study has uncovered gene clues that could pave the way to personalised psoriasis treatments. Psoriasis is a common inflammatory skin disease linked to several long-term health conditions,…
A recent randomized, double-blind, placebo-controlled clinical trial found that duloxetine significantly reduced the frequency and sensitivity of refractory chronic cough (RCC) compared with placebo. Patients treated with duloxetine had a…
In patients with peripheral vascular disease (PVD) undergoing peripheral vascular intervention (PVI), both intravenous and oral hydration protocols were effective and safe in preventing contrast-induced nephropathy (CIN). Oral hydration was…
Chlamydia pneumoniae-a common bacterium that causes pneumonia and sinus infections-can linger in the eye and brain for years and may aggravate Alzheimer’s disease, according to a study from Cedars-Sinai. Published…
There is no consensus of whether to use a short or long intramedullary nail (IMN) in the treatment of trochanteric and subtrochanteric fractures. In the retrospective cohort study, Peter Sverre…
New Delhi: In an alarming indictment of India's pharmaceutical pricing system, the Parliamentary Standing Committee on Chemicals and Fertilizers has flagged massive profiteering by pharmaceutical companies, revealing that life-saving medicines…
New Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Carbidopa, Levodopa and Entacapone Tablets,…
New Delhi: Zydus Lifesciences Limited on Wednesday announced that the United States Food and Drug Administration (USFDA) has granted Orphan Drug Designation (ODD) to its novel New Chemical Entity (NCE)…
Hyderabad: Gland Pharma Limited, a generic injectable and ophthalmic-focused pharmaceutical company, has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA)…
Guwahati: Leading drug maker Sun Pharmaceutical will invest Rs 500 crore to set up a manufacturing plant in Assam, generating direct employment for over 500 people, Chief Secretary Ravi Kota…